Gross pharmaceutical expenditure by the Italian NHS on prescription drugs 2012-2022

Between 2012 and 2021, the gross pharmaceutical expenditure on class A prescription drugs by the National Healthcare Service (NHS) in Italy decreased constantly. According to the data, in fact, in 2012 total spending on prescription drugs amounted to roughly 11.5 billion euros, while by 2021 this figure dropped to roughly 9.7 billion euros. A slight increase was observed in 2022, when the gross pharmaceutical expenditure in Italy amounted to almost 9.9 billion euros. This statistic shows the gross pharmaceutical expenditure by the National Healthcare Service on class A prescription drugs sold in pharmacies in Italy from 2012 to 2022 (in million euros).

自2012年至2021年，意大利国家卫生服务局（NHS）在A类处方药上的总药费支出持续下降。据数据显示，实际上，2012年处方药的总支出约为115亿欧元，而到2021年，这一数字降至约97亿欧元。2022年观察到轻微的增长，当年意大利的药品总支出接近99亿欧元。此统计数据展示了2012年至2022年间，意大利国家卫生服务局在药店销售的A类处方药上的总药费支出（单位：百万欧元）。